Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C15orf52 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | CNTNAP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | NECTIN4 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | RP13-347D8.7 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | NFATC2 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
mRNA | DUSP10 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | S100B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | MAGEB16 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PLXNB2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | ITCH | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |